Sangamo Therapeutics SGMO reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Sangamo Therapeutics beat estimated earnings by 17.14%, reporting an EPS of $-0.29 versus an estimate of $-0.35.
Revenue was up $1.51 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 3.72% drop in the share price the next day.
Here's a look at Sangamo Therapeutics's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Sangamo Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.